Dose Escalation Followed by Study of RAD001 in Combination With Trastuzumab in HER2-Positive Metastatic Breast Cancer
Clinical trial NCT00458237 · COMPLETED
Trial details
- NCT number
- NCT00458237
- Sponsor
- Beth Israel Deaconess Medical Center
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-04-01
- Primary completion
- 2010-04-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.